Clinical Trial Update: Gonadotropin-releasing Hormone Agonist Prior to Myomectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a gonadotropin-releasing hormone (GnRH) agonist administered before myomectomy for uterine fibroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Lupron (leuprolide)

Snippet

Sponsor: Mt. Hope Maternity Hospital | Conditions: Fibroids | Phase 3 | Status: COMPLETED